204 related articles for article (PubMed ID: 22129181)
1. Correlation of histopathologic follow-up findings with vaginal human papillomavirus and low-grade squamous intraepithelial lesion Papanicolaou test results.
Bansal M; Austin RM; Zhao C
Arch Pathol Lab Med; 2011 Dec; 135(12):1545-9. PubMed ID: 22129181
[TBL] [Abstract][Full Text] [Related]
2. Significance of high-risk human papillomavirus DNA detection in women 50 years and older with squamous cell papanicolaou test abnormalities.
Zhao C; Zhao S; Heider A; Austin RM
Arch Pathol Lab Med; 2010 Aug; 134(8):1130-5. PubMed ID: 20670132
[TBL] [Abstract][Full Text] [Related]
3. Cytology and human papillomavirus screening test results associated with 2827 histopathologic diagnoses of cervical intraepithelial neoplasia 2/3.
Zhao C; Amin M; Weng B; Chen X; Kanbour-Shakir A; Austin RM
Arch Pathol Lab Med; 2013 Jul; 137(7):942-7. PubMed ID: 23050808
[TBL] [Abstract][Full Text] [Related]
4. Detection of Human Papillomavirus Infection in Patients with Vaginal Intraepithelial Neoplasia.
Lamos C; Mihaljevic C; Aulmann S; Bruckner T; Domschke C; Wallwiener M; Paringer C; Fluhr H; Schott S; Dinkic C; Brucker J; Golatta M; Gensthaler L; Eichbaum M; Sohn C; Rom J
PLoS One; 2016; 11(12):e0167386. PubMed ID: 27907089
[TBL] [Abstract][Full Text] [Related]
5. Clinical performance of hybrid capture 2 human papillomavirus testing for recurrent high-grade cervical/vaginal intraepithelial neoplasm in patients with an ASC-US Papanicolaou test result during long-term posttherapy follow-up monitoring.
De Vivar AD; Dawlett M; Wang JP; Jack A; Gong Y; Staerkel G; Guo M
Arch Pathol Lab Med; 2015 Feb; 139(2):219-24. PubMed ID: 25611104
[TBL] [Abstract][Full Text] [Related]
6. Histopathologic follow-up and human papillomavirus DNA test results in 290 patients with high-grade squamous intraepithelial lesion Papanicolaou test results.
Gao FF; Austin RM; Zhao C
Cancer Cytopathol; 2011 Dec; 119(6):377-86. PubMed ID: 21774093
[TBL] [Abstract][Full Text] [Related]
7. Immediate histopathologic follow-up of cervista and aptima high-risk HPV assays in women with LSIL cytology.
Zhang H; Varma KR; Han M; Matsko J; Zhao C
Cancer Cytopathol; 2018 Aug; 126(8):525-532. PubMed ID: 29797678
[TBL] [Abstract][Full Text] [Related]
8. Low-grade squamous intraepithelial lesion/cannot exclude high-grade squamous intraepithelial lesion (LSIL-H) is a unique category of cytologic abnormality associated with distinctive HPV and histopathologic CIN 2+ detection rates.
Barron S; Li Z; Austin RM; Zhao C
Am J Clin Pathol; 2014 Feb; 141(2):239-46. PubMed ID: 24436272
[TBL] [Abstract][Full Text] [Related]
9. Follow-up with histopathology and HPV testing on LSIL cytology in China's largest academic woman's hospital.
Tao X; Zhang H; Zhang H; Xiao J; Li J; Zhou X; Wang L; Zhao C
Cancer Cytopathol; 2019 Apr; 127(4):258-266. PubMed ID: 30892831
[TBL] [Abstract][Full Text] [Related]
10. Clinical performance of the Food and Drug Administration-Approved high-risk HPV test for the detection of high-grade cervicovaginal lesions.
Zhou H; Mody RR; Luna E; Armylagos D; Xu J; Schwartz MR; Mody DR; Ge Y
Cancer Cytopathol; 2016 May; 124(5):317-23. PubMed ID: 26774025
[TBL] [Abstract][Full Text] [Related]
11. Distribution of human papillomavirus types in ThinPrep Papanicolaou tests classified according to the Bethesda 2001 terminology and correlations with patient age and biopsy outcomes.
Evans MF; Adamson CS; Papillo JL; St John TL; Leiman G; Cooper K
Cancer; 2006 Mar; 106(5):1054-64. PubMed ID: 16421920
[TBL] [Abstract][Full Text] [Related]
12. Low-grade squamous intraepithelial lesion, cannot rule out high-grade lesion: Diagnosis, histological outcomes and human papillomavirus results.
Segura SE; Ramos-Rivera G; Hakima L; Suhrland M; Khader S
Cytopathology; 2019 Jan; 30(1):99-104. PubMed ID: 30187975
[TBL] [Abstract][Full Text] [Related]
13. Low-grade squamous intraepithelial lesion on Papanicolaou test: follow-up rates and stratification of risk for high-grade squamous intraepithelial lesion.
Rufail M; Lew M; Pang J; Jing X; Heider A; Cantley RL
J Am Soc Cytopathol; 2020; 9(4):258-265. PubMed ID: 32402830
[TBL] [Abstract][Full Text] [Related]
14. The distribution of low and high-risk HPV types in vulvar and vaginal intraepithelial neoplasia (VIN and VaIN).
Srodon M; Stoler MH; Baber GB; Kurman RJ
Am J Surg Pathol; 2006 Dec; 30(12):1513-8. PubMed ID: 17122506
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of high-risk human papillomavirus in women with abnormal and normal vaginal ThinPrep Papanicolaou cytology.
Bansal M; Zhao C
J Low Genit Tract Dis; 2011 Apr; 15(2):105-9. PubMed ID: 21317806
[TBL] [Abstract][Full Text] [Related]
16. Follow-up outcomes for a large cohort of US women with negative imaged liquid-based cytology findings and positive high risk human papillomavirus test results.
Zhao C; Chen X; Onisko A; Kanbour A; Austin RM
Gynecol Oncol; 2011 Aug; 122(2):291-6. PubMed ID: 21601911
[TBL] [Abstract][Full Text] [Related]
17. HPV detection rates and histopathologic follow-up of patients with HSIL cytology in a large academic women's hospital laboratory.
Ashman D; Zhang H; Li J; Austin M; Wang T; Pradhan D; Zhao C
J Am Soc Cytopathol; 2020; 9(6):550-555. PubMed ID: 32475726
[TBL] [Abstract][Full Text] [Related]
18. A retrospective study of cytology and HPV genotypes results of 3229 vaginal intraepithelial neoplasia patients.
Ao M; Zheng D; Wang J; Gu X; Xi M
J Med Virol; 2022 Feb; 94(2):737-744. PubMed ID: 34460120
[TBL] [Abstract][Full Text] [Related]
19. Vaginal intraepithelial neoplasia in patients after total hysterectomy.
Cao D; Wu D; Xu Y
Curr Probl Cancer; 2021 Jun; 45(3):100687. PubMed ID: 33309077
[TBL] [Abstract][Full Text] [Related]
20. Aptima HPV messenger RNA testing and histopathologic follow-up in women with HSIL cytology: A study emphasizing additional review of HPV-negative cases.
Li A; Li J; Austin RM; Wang T; Ashman D; Zhang H; Matsko J; Zhao C
Cancer Cytopathol; 2021 Aug; 129(8):622-631. PubMed ID: 33764649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
